Vanja Sikirica

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Rheumatoid Arthritis

Emergency Department

Systematic Review

Top Venues

Orphanet journal of rare diseases

Neurology and therapy

Journal of medical economics

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Shailja Vaghela, Kaniz Afroz Tanni, Geetanjoli Banerjee, Vanja Sikirica
A systematic review of real-world evidence (RWE) supportive of new drug and biologic license application approvals in rare diseases. Orphanet journal of rare diseases 19 (1) (2024)
Wei Gao, Arash Mostaghimi, Kavita Gandhi, Nicolae Done, Markqayne Ray, James E Signorovitch, Elyse Swallow, Christopher Carley, Travis Wang, Vanja Sikirica
Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States. Journal of medical economics (2023)
Shoshana R Daniel, Kavita Gandhi, Kathryn P Anastassopoulos, Amit G Pandya, Vanja Sikirica, Reema Patel, Lynne Napatalung, Yuji Yamaguchi, Rebecca Baik, Khaled Ezzedine
Impact of nonsegmental vitiligo on patients' health-related quality of life in the United States. The British journal of dermatology 187 (4) (2022)
Vanja Sikirica, Per A Gustafsson, Charles Makin
Treatment Patterns among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder with or without Psychiatric or Neurologic Comorbidities in Sweden: A Retrospective Cohort Study. Neurology and therapy 6 (1) (2017)